Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

2.47
Delayed Data
As of Mar 27
 +0.03 / +1.23%
Today’s Change
1.00
Today|||52-Week Range
8.46
-3.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-20.1M-44.0M-34.6M--
 
 
 
 
Depreciation56.0K31.0K20.0K--
 
 
 
 
Total Other Cash Flow-4.2M10.5M4.3M--
 
 
 
 
Funds From Operations-24.3M-33.4M-30.3M--
 
 
 
 
Funds From/For Other Operating Expenses-1.5M-22.7M7.1M--
 
 
 
 
Net Cash Flow - Operating Activities-22.8M-10.6M-37.4M-43.2M
 
 
 
 
 
 
InvestingIncrease In Investments-52.1M-67.6M-26.9M--
 
 
 
 
Decrease In Investments56.2M46.2M59.1M--
 
 
 
 
Capital Expenditures-15.0K0.000.00--
 
 
Fixed Asset Disposal34.0K11.0K0.00--
 
 
 
Net Cash Flow Investing4.2M-21.4M32.2M--
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings9.6M15.0M0.009.4M
 
 
 
 
Long Term Debt Reduction0.000.00-7.2M-9.4M
 
 
 
Net Proceeds Stock Sale4.1M19.5M12.6M56.3M
 
 
 
 
 
Common Preferred Redeemed0.000.000.00----
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.003.1M0.00--
 
 
Other Uses - Financing0.000.000.00----
Net Cash Flow - Financing13.7M37.6M5.4M56.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.00----
 
Net Change In Cash-4.9M5.6M181.0K13.1M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account